Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07193485

Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
65 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective

Detailed description

forty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I or group II. the group enroled 20 seniors. both groups wil take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.

Conditions

Interventions

TypeNameDescription
OTHERButeyko breathingtwenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.
OTHERusual caretwenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks.

Timeline

Start date
2025-05-12
Primary completion
2025-10-10
Completion
2025-10-10
First posted
2025-09-25
Last updated
2025-09-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07193485. Inclusion in this directory is not an endorsement.